Language characterization in 16p11.2 deletion and duplication syndromes
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · 2020-09 · 183 (6) · 380-391
DOI: 10.1002/ajmg.b.32809 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, online erschienen am 11.07.2020. Verfasst von So Hyun Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Weill Cornell Medicine, White Plains, New York, USA. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Simons Foundation.
Abstract (Originalsprache)
Expressive language impairment is one of the most frequently associated clinical features of 16p11.2 copy number variations (CNV). However, our understanding of the language profiles of individuals with 16p11.2 CNVs is still limited. This study builds upon previous work in the Simons Variation in Individuals Project (VIP, now known as Simons Searchlight), to characterize language abilities in 16p11.2 deletion and duplication carriers using comprehensive assessments. Participants included 110 clinically ascertained children and family members (i.e., siblings and cousins) with 16p11.2 BP4‐BP5 deletion and 58 with 16p11.2 BP4‐BP5 duplication between the ages of 2–23 years, most of whom were verbal. Regression analyses were performed to quantify variation in language abilities in the presence of the 16p11.2 deletion and duplication, both with and without autism spectrum disorder (ASD) and cognitive deficit. Difficulties in pragmatic skills were equally prevalent in verbal individuals in both deletion and duplication groups. NVIQ had moderate quantifiable effects on language scores in syntax and semantics/pragmatics (a decrease of less than 1 SD ) for both groups. Overall, language impairments persisted even after controlling for ASD diagnosis and cognitive deficit. Language impairment is one of the core clinical features of individuals with 16p11.2 CNVs even in the absence of ASD and cognitive deficit. Results highlight the need for more comprehensive and rigorous assessment of language impairments to maximize outcomes in carriers of 16p11.2 CNVs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, Weill Cornell Medicine, White Plains, New York, USA.
- Simons Foundation, New York, New York, USA.
- Semel Institute for Neuroscience and Behavior, University of California Los Angeles, California, Los Angeles, USA.
- Department of Psychiatry, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California, USA.
- Department of Neurology, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA.
- Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA.
ORCID-Profile: So Hyun Kim, Kyle J Steinman
Förderung
- NICHD NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Simons Foundation
Zitieren
APA
Kim, S. H., Green-Snyder, L., Lord, C., Bishop, S., Steinman, K. J., Bernier, R., Hanson, E., Goin-Kochel, R. P., & Chung, W. K. (2020). Language characterization in 16p11.2 deletion and duplication syndromes. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 183(6), 380-391. https://doi.org/10.1002/ajmg.b.32809
Vancouver
Kim SH, Green-Snyder L, Lord C, Bishop S, Steinman KJ, Bernier R, et al. Language characterization in 16p11.2 deletion and duplication syndromes. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2020;183(6):380-391. doi:10.1002/ajmg.b.32809
BibTeX
@article{Kim2020,
author = {Kim, So Hyun and Green-Snyder, LeeAnne and Lord, Catherine and Bishop, Somer and Steinman, Kyle J and Bernier, Raphael and Hanson, Ellen and Goin-Kochel, Robin P and Chung, Wendy K},
title = {Language characterization in 16p11.2 deletion and duplication syndromes},
journal = {American Journal of Medical Genetics Part B: Neuropsychiatric Genetics},
year = {2020},
volume = {183},
number = {6},
pages = {380--391},
doi = {10.1002/ajmg.b.32809}
}
EUVIMED